Annual Cash & Cash Equivalents
$88.40 M
+$34.76 M+64.80%
December 31, 2023
Summary
- As of February 8, 2025, ARQT annual cash & cash equivalents is $88.40 million, with the most recent change of +$34.76 million (+64.80%) on December 31, 2023.
- During the last 3 years, ARQT annual cash & cash equivalents has risen by +$23.32 million (+35.83%).
- ARQT annual cash & cash equivalents is now -8.35% below its all-time high of $96.45 million, reached on December 31, 2021.
Performance
ARQT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$134.85 M
+$50.58 M+60.02%
September 30, 2024
Summary
- As of February 8, 2025, ARQT quarterly cash and cash equivalents is $134.85 million, with the most recent change of +$50.58 million (+60.02%) on September 30, 2024.
- Over the past year, ARQT quarterly cash and cash equivalents has increased by +$27.38 million (+25.48%).
- ARQT quarterly cash and cash equivalents is now -53.29% below its all-time high of $288.69 million, reached on March 31, 2021.
Performance
ARQT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ARQT Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +64.8% | +25.5% |
| 3 y3 years | +35.8% | +25.5% |
| 5 y5 years | +124.4% | +25.5% |
ARQT Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -8.3% | +64.8% | -29.1% | +151.4% |
| 5 y | 5-year | -8.3% | +64.8% | -53.3% | +195.0% |
| alltime | all time | -8.3% | +2486.3% | -53.3% | +481.8% |
Arcutis Biotherapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $134.85 M(+60.0%) |
| Jun 2024 | - | $84.27 M(-55.7%) |
| Mar 2024 | - | $190.10 M(+115.0%) |
| Dec 2023 | $88.40 M(+64.8%) | $88.40 M(-17.7%) |
| Sep 2023 | - | $107.47 M(+2.2%) |
| Jun 2023 | - | $105.11 M(+29.1%) |
| Mar 2023 | - | $81.41 M(+51.8%) |
| Dec 2022 | $53.64 M(-44.4%) | $53.64 M(-34.2%) |
| Sep 2022 | - | $81.54 M(+32.6%) |
| Jun 2022 | - | $61.51 M(-11.9%) |
| Mar 2022 | - | $69.80 M(-27.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $96.45 M(+48.2%) | $96.45 M(+86.3%) |
| Sep 2021 | - | $51.78 M(-41.9%) |
| Jun 2021 | - | $89.13 M(-69.1%) |
| Mar 2021 | - | $288.69 M(+343.6%) |
| Dec 2020 | $65.08 M(+2.8%) | $65.08 M(+42.4%) |
| Sep 2020 | - | $45.71 M(-73.4%) |
| Jun 2020 | - | $171.55 M(-10.1%) |
| Mar 2020 | - | $190.89 M(+201.4%) |
| Dec 2019 | $63.34 M(+60.8%) | $63.34 M(+173.3%) |
| Sep 2019 | - | $23.18 M(-41.2%) |
| Dec 2018 | $39.39 M(+1052.5%) | $39.39 M |
| Dec 2017 | $3.42 M | - |
FAQ
- What is Arcutis Biotherapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics annual cash & cash equivalents year-on-year change?
- What is Arcutis Biotherapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics quarterly cash and cash equivalents year-on-year change?
What is Arcutis Biotherapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of ARQT is $88.40 M
What is the all time high annual cash & cash equivalents for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high annual cash & cash equivalents is $96.45 M
What is Arcutis Biotherapeutics annual cash & cash equivalents year-on-year change?
Over the past year, ARQT annual cash & cash equivalents has changed by +$34.76 M (+64.80%)
What is Arcutis Biotherapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ARQT is $134.85 M
What is the all time high quarterly cash and cash equivalents for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high quarterly cash and cash equivalents is $288.69 M
What is Arcutis Biotherapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, ARQT quarterly cash and cash equivalents has changed by +$27.38 M (+25.48%)